The News Infusion – Newsletter
Hemophilia of South Carolina’s official newsletter, The News Infusion, is distributed throughout the state of South Carolina to registered members of HSC and to the Chapter’s national and local affiliations. It is endorsed by the National Hemophilia Foundation and the Hemophilia Treatment Center.
The News Infusion is published quarterly by Hemophilia of South Carolina as an informational service for its members, friends, and affiliations of South Carolina’s bleeding disorder community. It provides communication connections, education, and advocacy awareness. The News Infusion does not endorse any provider, company or product and further recommends that its readers always consult with their physicians and health care providers.
Statement of Purpose
The News Infusion editorial staff recognize that it must meet the needs of its readership; specifically, to include:
- Timely knowledge regarding the activities of Hemophilia of South Carolina and its governing board;
- Information from the Hemophilia Treatment Centers which also involves the Chapter’s goals and its members;
- Facts and informational articles from the National Hemophilia Foundation, Hemophilia Federation of America and other affiliations and their activities.
- Data and information regarding the research, market and application of treatment developments for bleeding disorders;
- Forum for the exchange of information, ideas, and opinions among the chapter, its members and supporters.
The editorial staff ultimately is responsible to Hemophilia of South Carolina’s Board of Directors, which reserves the right to edit, remove or refuse any content that does not meet the needs of its readership. The Newsletter should always depict the fundamental elements of the Mission of the Chapter; the purpose of this organization shall be to promote awareness of bleeding disorders to the general public; provide education and support to persons with bleeding disorders and their families; and support research of The National Hemophilia Foundation.